Persistence of bactericidal antibodies following booster vaccination with 4CMenB at 12, 18 or 24 months and immunogenicity of a fifth dose administered at 4 years of age-a phase 3 extension to a randomised controlled trial

Published 2017 View Full Article

Authors

Keywords

4CMenB, Neisseria meningitidis, Vaccine, Reactogenicity, MenW, Toddler

Journal

VACCINE

Volume 35, Issue 2, Pages 395-402

Publisher

Elsevier BV

Online

2016-12-01

DOI

10.1016/j.vaccine.2016.11.009

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started